News

Ichnos Glenmark Innovation receives upfront payment of $700 million from AbbVie

The payment is in accordance with the agreed contractual terms

Ichnos Glenmark Innovation (IGI), Glenmark's wholly owned subsidiary, has received an upfront payment of $700 million from AbbVie.

The payment is in accordance with the agreed contractual terms and is being made towards an exclusive global licensing agreement for IGI's lead investigational asset, ISB 2001 across North America, Europe, Japan, and Greater China markets.

Upcoming E-conference

Other Related stories

SPL Infusion commences commercial production of new IV fluid Infusion plant

Alcon India launches Unity VCS/CS for vitreoretinal and cataract surgery

Congruence gets $32 million financing to advance genetic obesity candidate drug

Interviews

India rema

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

Capex comm

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Our focus

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Appointments

Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)

Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer

Eli Lilly appoints Dr. Vivek Jha as Senior Director – Commercial Strategy, AI & Transformation

Eli Lilly appoints Dr. Vivek Jha as Senior Director – Commercial Strategy, AI & Transformation

Startup

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem

Healthium and C-CAMP launch innovations program for surgical and medical technologies

Healthium and C-CAMP launch innovations program for surgical and medical technologies

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh

Digitization

HealthEdge and UST HealthProof Merge to create AI-powered healthcare payer technology

HealthEdge and UST HealthProof Merge to create AI-powered healthcare payer technology

Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India

Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India

HGM acquires Aideo Technologies for Rs. 14 crore to strengthen AI-powered healthcare services platform

HGM acquires Aideo Technologies for Rs. 14 crore to strengthen AI-powered healthcare services platform

Latest Stories

SPL Infusion commences commercial production of new IV fluid Infusion plant

Ichnos Glenmark Innovation receives upfront payment of $700 million from AbbVie

Alcon India launches Unity VCS/CS for vitreoretinal and cataract surgery

Congruence gets $32 million financing to advance genetic obesity candidate drug

Biocytogen and Merck to advance antibody-conjugated lipid-based delivery solutions

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Dr. R. Ananthanarayanan CEO, Sajjan India

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging

UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging

UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging

Sanner commences manufacturing critical injection-molded components in USA

Sanner commences manufacturing critical injection-molded components in USA

UFlex introduces FSSAI compliant single-pellet solution for food packaging

UFlex introduces FSSAI compliant single-pellet solution for food packaging